Since Nlrp3 inflammasome controls IL-1β processing and secretion, and pyroptosome formation (which is a down-stream event of IL-1β-IL-1RI signaling) leads to AM pyroptosis, the findings from the current study suggest that targeting multiple molecules may represent a therapeutic strategy for controlling inflammation during bacterial infection. The gene discussed is IL1B; the disease is bacterial infectious disease.